Kao Corp. Stock
€33.44
Your prediction
Kao Corp. Stock
Pros and Cons of Kao Corp. in the next few years
Pros
Cons
Performance of Kao Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kao Corp. | 2.920% | 3.146% | 4.337% | -15.256% | -2.422% | -0.772% | -35.593% |
| Unicharm Corp. | 0.990% | 4.622% | -3.301% | - | 2.469% | - | - |
| Pola Orbis Holdings Inc. | 0.760% | -1.493% | -1.493% | -14.839% | -5.036% | -51.825% | -71.053% |
| Kose Corp | -1.440% | -1.429% | -2.128% | -19.298% | -1.429% | -70.481% | -79.706% |
News
Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insiders
On May 11, 2026, John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 298,000 shares of common stock for a total transaction value of
Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes
Alignment Healthcare (NASDAQ:ALHC) executives said the company remains confident in its second-quarter outlook, citing stable medical cost
Alignment Healthcare CEO Sells $2.1 Million in Shares. Here's What Investors Should Know
John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 118,000 shares for a transaction value of about $2.06 million, according to a SEC Form 4


